RxDoctor Payments Data

Upton Siddons, MD

Family Medicine · Greenwood, ARNPI 1871084301

Payments from drug & device makers

$854in general payments, 2019–2025

Across 47 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$213
  • Paratek Pharmaceuticals, Inc.$109
  • Dexcom, Inc.$85
  • Otsuka America Pharmaceutical, Inc.$79
  • Novo Nordisk$73
  • Sanofi-aventis U.S. LLC$55
  • plus $239 from 12 others

What the payments were for

  • Food & beverage$854100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$854 in reported general payments places this provider in the 55th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$81,633
Medicare patients
290
Services billed
1,556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban159$86,679
JardianceEmpagliflozin75$64,891
TrulicityDulaglutide36$55,220
OzempicSemaglutide34$38,484
MounjaroTirzepatide30$31,174
Tresiba Flextouch U-200Insulin Degludec35$29,582
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$28,419
NuedextaDextromethorphan Hbr/Quinidine26$19,828
FarxigaDapagliflozin Propanediol30$17,818
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$16,779
Soliqua 100-33Insulin Glargine/Lixisenatide12$16,420
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$12,354
VraylarCariprazine Hcl14$10,035
LinzessLinaclotide17$8,936
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$8,819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$86,679159 claims
Lilly USA, LLCTrulicity, Mounjaro$13$86,39566 claims
Novo NordiskOzempic$73$38,48434 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$213$34,81369 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Multaq, Lantus$55$24,03944 claims
AbbVieVraylar, Linzess$44$18,97231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Greenwood

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →